Amalgamated Financial’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Amalgamated Financial’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$231K	Buy	+5,599	New	+$197K	﹤0.01%	1850

Other funds holding SILK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Amalgamated Financial's SILK Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Silk Road Medical, Inc. Common Stock (SILK) in Q1 2022: 5,599 shares worth $231K. The stake represents ﹤0.01% of the portfolio and ranks #1850 among its holdings.

153 funds tracked by Wall St. Rank hold SILK as of Q1 2022.

Amalgamated Financial held 5,599 shares of Silk Road Medical, Inc. Common Stock worth $231K as of Q1 2022.
Silk Road Medical, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
Silk Road Medical, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1850 holding.
153 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.